IDA blend vs Iraq: Cause of death, by non-communicable diseases, ages 60+
IDA blend
69.7%
in 2021
Iraq
83.2%
in 2021
IDA blend rank
28th
Iraq rank
30th
Cause of death, by non-communicable diseases, ages 60+ over time
- IDA blend
- Iraq
How they compare
Iraq currently reports 83.2% against 69.7% in IDA blend, a difference of 13.5%.
That makes Iraq's figure about 1.2 times IDA blend's.
Across all 6 years both countries report, Iraq has been ahead every year.
IDA blend ranks 28th and Iraq ranks 30th of 47 groups.
Iraq has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | IDA blend | Iraq | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 71.7% | 93.5% | 21.8% | Iraq |
| 2010s | 77.2% | 93.5% | 16.3% | Iraq |
| 2020s | 70.9% | 81.6% | 10.6% | Iraq |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cause of death, by non-communicable diseases, ages 60+, IDA blend or Iraq?
- Iraq, at 83.2% against 69.7% in IDA blend as of 2021.
- What is the difference in cause of death, by non-communicable diseases, ages 60+ between IDA blend and Iraq?
- 13.5%, with Iraq ahead.
- How many years of comparable data are there for IDA blend and Iraq?
- 6 years are reported by both, from 2000 to 2021.
- How do IDA blend and Iraq rank globally for cause of death, by non-communicable diseases, ages 60+?
- IDA blend ranks 28th and Iraq ranks 30th of 47 groups.
- Where does this data come from?
- Global Health Estimates, World Health Organization (WHO), published as Cause of death, by non-communicable diseases, ages 60+ (% of total deaths ages 60+). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of deaths ages 60+ due to non-communicable diseases divided by number of all deaths ages 60+, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.